Author | Haythem Y. Ali, MD | OncLive

Author | Haythem Y. Ali, MD

Articles

Dr. Ali on Adjuvant Studies With Biosimilars in Oncology

September 19, 2018

Haythem Y. Ali, MD, senior medical oncologist, Henry Ford Hospital, discusses adjuvant studies with biosimilars in oncology.

Dr. Ali on Whether Biosimilars Can Replace Biologics in Oncology

August 30, 2018

Haythem Y. Ali, MD, senior medical oncologist, Henry Ford Hospital, discusses whether biosimilars can replace biologics in oncology.

Dr. Ali on Choosing Neratinib in HER2+ Breast Cancer

July 12, 2018

Haythem Y. Ali, MD, senior medical oncologist, Henry Ford Hospital, discusses neratinib (Nerlynx) in the treatment of patients with HER2-positive breast cancer.

Dr. Ali on the Future of Adjuvant Care for HER2+ Breast Cancer

June 21, 2018

Haythem Y. Ali, MD, senior medical oncologist, Henry Ford Hospital, discusses the future of adjuvant treatment for patients with HER2-positive breast cancer.

x